Outlook Therapeutics
NASDAQ: OTLK
$0.47
+0.00
(+0.21%)
as on
Outlook Therapeutics Stock Performance
as on November 3, 2026 at 7:59 am IST
Day's Low
Day's High
$0.45$0.48
4.07%
Downside
2.32%
Upside
52 Week's Low
52 Week's High
$0.16$2.5465.66%
Downside
440.93%
Upside
Outlook Therapeutics share price movements today
- Previous Close
- $0.47
- Open
- $0.47
- Volume
- 2.4M
- Market Cap
- $114.0M
- Day's Low - High
- $0.45 - $0.48
- 52 Week Low - High
- $0.16 - $2.54
Outlook Therapeutics Historical Returns
- 1 Month Return
- -21.06 %
- 3 Month Return
- -52.07 %
- 1 Year Return
- -62.85 %
- 3 Year Return
- -93.12 %
- 5 Year Return
- -98.88 %
Outlook Therapeutics Stock Fundamentals & Key Indicators
Check Outlook Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$114.0M
EPS (TTM)
-1.1
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.43
Industry PE ratio
-3.13
PEG Ratio
0.00
EBITDA
-62.3M
Revenue (TTM)
-1.2M
Profit Margin
195.64%
Return On Equity TTM
222.01%
Outlook Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Outlook Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $114.0M | -98.88% | -0.43 | 195.64% | 0.00% | |
| Neutral | $88.5B | -36.40% | -27.78 | -12.57% | 0.00% | |
| StrongBuy | $141.7B | 208.09% | 32.27 | 86.04% | 0.00% | |
| Buy | $95.5B | 45.26% | 19.76 | 85.77% | 0.40% |
Stock Returns calculator for Outlook Therapeutics Stock including INR - Dollar returns
The Outlook Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Outlook Therapeutics investment value today
Current value as on today
₹39,822
Returns
Returns from Outlook Therapeutics Stock
Dollar Impact
₹2,592 (+2.59%)
Analyst Recommendation on Outlook Therapeutics Stock
Based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Outlook Therapeutics. Average target price of $5.03
Outlook Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Outlook Therapeutics.
What analysts predicted
90.67%UPSIDE
Target Price
$5.03
Current Price
$0.4691
Analyzed by
1 Analysts
High
$4
Target
$5.03
Low
$4
Outlook Therapeutics target price $5.03, a slight upside of 90.67% compared to current price of $0.4691. According to 1 analysts rating.
Indian Investors' Interest in Outlook Therapeutics Stock
Search interest for Outlook Therapeutics Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Outlook Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Outlook Therapeutics Annual Profit & Loss
All numbers in Millions USD
Outlook Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Outlook Therapeutics Annual Cash Flow
All numbers in Millions USD
Outlook Therapeutics News & Key Events
Today's Timeline - 01 October
Thu, 06:31 PM
-Outlook Therapeutics submits application for HCPCS Level II J-code for LYTENAVA, advancing U.S. commercialization strategy.
Insights on Outlook Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Moderna, Inc. Common Stock has given 211.3% return, outperforming this stock by 304.4%
- NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 716.3% return, outperforming this stock by 779.1%
NEGATIVE IMPACTPrice Dip
In the last 7 days, OTLK stock has moved down by -8.8%
About Outlook Therapeutics
| Organisation | Outlook Therapeutics |
| Headquarters | 111 S. Wood Avenue, Iselin, NJ, 08830, US |
| Industry | Biotechnology |
| CEO | Robert Charles Jahr |
Key Management of Outlook Therapeutics
Name | Title |
|---|---|
Mr. Robert Charles Jahr | President, CEO & Director |
Mr. Kevin Lundquist | CFO, Treasurer, Principal Financial Officer & Principal Accounting Officer |
Mr. Joel Prieve | Senior Vice President of Licensing and M&A |
Dr. Surendra Sharma M.D. | Senior Vice President of Medical Affairs |
Dr. Jennifer M. Kissner Ph.D. | Senior Vice President of Clinical Development & Regulatory Affairs |
Mr. Jedd Comiskey | Senior VP - Head of Europe |
FAQs
What is Outlook Therapeutics share price today?
Outlook Therapeutics share price today is $0.47 as on at the close of the market. Outlook Therapeutics share today touched a day high of $0.48 and a low of $0.45.
What is the 52 week high and 52 week low for Outlook Therapeutics share?
Outlook Therapeutics share touched a 52 week high of $2.54 on and a 52 week low of $0.16 on . Outlook Therapeutics stock price today i.e. is closed at $0.47,which is 81.51% down from its 52 week high and 191.19% up from its 52 week low.
What is Outlook Therapeutics's market capitalisation today?
Outlook Therapeutics market capitalisation is $0.00T as on .
How to invest in Outlook Therapeutics Stock (OTLK) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Outlook Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Outlook Therapeutics Stock (OTLK) from India?
Indian investors can start investing in Outlook Therapeutics (OTLK) shares with as little as ₹94.9000015258789 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Outlook Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Outlook Therapeutics share’s latest price of $0.47 as on November 3, 2026 at 2:29 am IST, you will get 21.3174 shares of Outlook Therapeutics. Learn more about
fractional shares .
What are the returns that Outlook Therapeutics has given to Indian investors in the last 5 years?
Outlook Therapeutics stock has given -98.88% share price returns and 27.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?